Insmed Overview
Insmed Target Price
Analysts' 12-month price predictions for INSM.
Share Price
$97.62
Average Target Price
$110.00
12.7% upside
12.7% upside1 analysts in the last 4 months
High: $110 | Low: $110
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-06 | UBS | $110 | 12.7% upside |  |
| 2024-08-15 | Mizuho SecuritiesGraig Suvannavejh | $92 |  5.8% downside | |
| 2024-08-09 | Wells FargoTiago Fauth | $85 | 12.9% downside | |
| 2024-07-09 | GuggenheimVamil Divan | $95 | 2.7% downside | |
| 2024-07-01 | Truist FinancialNicole Germino | $88 | 9.9% downside | |
| 2024-06-25 | BarclaysLeon Wang | $90 | 7.8% downside | |
| 2024-06-21 | Evercore ISILiisa Bayko | $75 | 23.2% downside | |
| 2024-06-07 | Mizuho SecuritiesGraig Suvannavejh | $82 | 16% downside | |
| 2024-06-05 | Stifel NicolausStephen Willey | $74 | 24.2% downside | |
| 2024-05-29 | Wells FargoTiago Fauth | $77 | 21.1% downside | |
| 2024-05-29 | H.C. WainwrightAndrew Fein | $70 | 28.3% downside | |
| 2024-05-29 | UBSTrung Huynh | $58 | 40.6% downside | |
| 2024-05-29 | Truist FinancialNicole Germino | $68 | 30.3% downside | |
| 2024-05-29 | Wolfe ResearchAndy Chen | $54 | 44.7% downside | |
| 2024-05-28 | Morgan StanleyJeffrey Hung | $60 | 38.5% downside | |
| 2024-05-28 | Goldman SachsAndrea Tan | $74 | 24.2% downside | |
| 2024-05-28 | Evercore ISILiisa Bayko | $42 | 57% downside | |
| 2024-05-13 | Mizuho SecuritiesGraig Suvannavejh | $36 | 63.1% downside | |
| 2024-05-09 | Morgan StanleyJeffrey Hung | $43 | 56% downside | |
| 2024-04-23 | Truist FinancialNicole Germino | $48 | 50.8% downside | |
| 2024-04-01 | Wells FargoTiago Fauth | $55 | 43.7% downside | |
| 2022-04-27 | Goldman Sachs | $56 | 42.6% downside | |